LIM-homeodomain (LIM-HD) transcription factors form a combinatorial 'LIM code' that contributes to the specification of cell types. In the ventral spinal cord, the binary LIM homeobox protein 3 (Lhx3)/LIM domain-binding protein 1 (Ldb1) complex specifies the formation of V2 interneurons. The additional expression of islet-1 (Isl1) in adjacent cells instead specifies the formation of motor neurons through assembly of a ternary complex in which Isl1 contacts both Lhx3 and Ldb1, displacing Lhx3 as the binding partner of Ldb1. However, little is known about how this molecular switch occurs. Here, we have identified the 30-residue Lhx3-binding domain on Isl1 (Isl1 LBD ). Although the LIM interaction domain of Ldb1 (Ldb1 LID ) and Isl1 LBD share low levels of sequence homology, X-ray and NMR structures reveal that they bind Lhx3 in an identical manner, that is, Isl1 LBD mimics Ldb1 LID . These data provide a structural basis for the formation of cell type-specific protein-protein interactions in which unstructured linear motifs with diverse sequences compete to bind protein partners. The resulting alternate protein complexes can target different genes to regulate key biological events.
Introduction
The formation of cell type-specific complexes is crucial for the development of complex organisms. Unique combinations of LIM-homeodomain (LIM-HD) proteins are thought to form a transcriptional 'LIM code' that is required for the specification of cell types within many different tissues and organs (reviewed in Gill, 2003) . LIM-HD proteins are characterised by two tandemly arrayed LIM domains at or near their N termini that mediate interactions with other proteins (Bach, 2000) , and a central homeodomain (HD) that recognises TAAT-containing DNA sequences. The LIM and HD regions share a high level of sequence conservation, but the C-terminal regions of the proteins are diverse.
The LIM domains from LIM-HD and related LIM-only (LMO) proteins bind to the LIM domain-binding (Ldb, also known as CLIM, NLI or CHIP) proteins, by means of an B30-residue LIM interaction domain (LID) on Ldb1 (Ldb1 LID ; Jurata et al, 1998; Deane et al, 2004) . This broadly expressed protein is involved in multiple developmental pathways (reviewed by Matthews and Visvader, 2003) . In LMO:Ldb1 complexes, Ldb1 LID binds as an extended peptide, stretching across both LIM domains in a head-to-tail fashion (Deane et al, 2003 (Deane et al, , 2004 . Ldb1 also contains an N-terminal self-association (SA) domain. Many of the biological activities of LIM-HD proteins depend on binding to Ldb1 oligomers, and at least two different LIM-HD or LMO proteins may simultaneously take part in Ldb1-containing complexes (Jurata et al, 1998) .
Specific transcriptional codes involving LIM-HDs are particularly important in the developing central nervous system of vertebrates where these proteins are important in the specification of a large number of distinct cell types. For example, the two LIM-HD proteins, Lhx3 (LIM homeobox protein 3) and Isl1 (Islet-1), act together with Ldb1 to specify two distinct cell types that lie adjacent to each other in the developing spinal cord, namely V2 interneurons and motor neurons. Ldb1 and Lhx3 are both present in developing V2 interneurons, whereas Isl1 is additionally expressed in postmitotic motor neurons (Pfaff et al, 1996; Sharma et al, 1998) . In the developing chick, the introduction of Isl1 into immature V2 interneurons gives rise to axonal outgrowths that are characteristic of motor neurons (Thaler et al, 2002) . Thaler et al also provided compelling evidence that in V2 interneurons Lhx3 binds Ldb1 directly to form a transcriptionally active complex, whereas the additional presence of Isl1 in motor neurons results in a situation where Isl1 directly contacts Ldb1 and Lhx3.
Here we used a combination of structural, mutagenic and biophysical approaches to identify the region of Isl1 that binds the LIM domains of Lhx3 (Isl1 LBD ) and to establish the structural basis for the specification of motor neurons by Lhx3, Isl1 and Ldb1. Our X-ray and NMR structures of Lhx3:Ldb1 LID and Lhx3:Isl1 LBD complexes demonstrate that, despite the low homology between Ldb1 LID and Isl1 LBD , the two proteins bind in an essentially identical bipartite manner. Simulations of complex formation for these proteins based on experimental binding data indicate that binary and ternary complexes are likely to target different genes.
Results

Identification of the Lhx3-binding domain on Isl1
The region of Ldb1 that binds LIM domains, Ldb1 LID , is well defined ( Figure 1A ; Jurata and Gill, 1997; Deane et al, 2004) ; however, the region on Isl1 that binds the LIM domains of Lhx3 was only roughly identified as lying C-terminal to the LIM domains in Isl1 ( Figure 1B ; Thaler et al, 2002) . We therefore generated a series of deletion mutants of Isl1 and used yeast two-hybrid (Y2H) analysis to precisely delineate the Lhx3/Isl1 interaction. Our data revealed a 30-residue sequence in Isl1 that binds the tandem LIM domains of Lhx3. Isl1 262-291 , hereafter termed the Lhx3-binding domain Isl1 LBD , lies C-terminal to the HD and N-terminal to the 16-residue Isl-specific domain (Thor and Thomas, 1997 ; Figure 1A and Supplementary data 1). Isl1 LBD and Ldb1 LID are essentially of the same length and share some slight sequence similarity near their N termini, but overall display very little sequence conservation. A far-UV CD spectrum of Isl1 LBD suggests that, similar to Ldb1 LID , the isolated domain is largely disordered ( Figure 1C ; Deane et al, 2004) . Using Y2H, we showed that Isl1 LBD was not able to interact with tandem LIM domains of Lhx3 (Lhx3 LIM1 þ 2 ) when the latter protein was expressed as a fusion with Ldb1 LID ( Figure 1D ; see below for a description of tethered complexes). Thus, we hypothesised that Ldb1 and Isl1 might contact the same or overlapping sites on Lhx3.
Structure determination of Lhx3-binding domain complexes
To test the above hypothesis, we determined the structures of Lhx3/Ldb1 and Lhx3/Isl1 complexes. The isolated LIM domains from Lhx3, similar to most other LIM-HD and LMO proteins, tend to be insoluble and/or aggregation prone; however, we have developed a strategy to circumvent these problems by generating tethered proteins in which the LIM domains are fused to the Ldb1 LID by a flexible glycine/serine linker (Deane et al, 2001) . Hence, we created tethered Lhx3 LIM1 þ 2 -Ldb1 LID and Lhx3 LIM1 þ 2 -Isl1 LBD complexes for structure determination. For the tethered Lhx3 LIM1 þ 2 -Ldb1 LID complex, we used restraints derived from multidimensional NMR data (Table I) , whereas we used X-ray crystallography for the Lhx3 LIM1 þ 2 -Isl1 LBD complex (Table II; Supplementary data 2). The solution structure of Lhx3 LIM1 þ 2 -Ldb1 LID Lhx3 LIM1 þ 2 -Ldb1 LID forms an elongated complex in which Ldb1 LID binds along the length of the tandem LIM domains of Lhx3 and the engineered linker that tethers the two proteins is unstructured (Figure 2A ). An overlay of the 20 lowest energy structures of Lhx3 LIM1 þ 2 -Ldb1 LID has a backbone RMSD of 1.4 Å over the structured regions of the complex (Lhx3 28-151 and Ldb1 301-327 ). However, each half of the complex is better defined, with backbone RMSDs of 0.70 Å for the 'LIM1 half' (Lhx3 28-89 and Ldb1 316-327 ; Figure 2B ) and 0.60 Å for the 'LIM2 half' (Lhx3 91-151 and Ldb1 301-311 ; Figure 2C ). Although These data suggest that the larger RMSD for the full complex might arise at least in part from a degree of mobility between the two LIM domains. In the ensemble, several residues that lie between the two halves of the complex, Lhx3 90 and Ldb1 [312] [313] [314] [315] , are less well defined (order angle parameters for j and c angles o0.8); these regions are hereafter referred to as the 'hinge' in Lhx3 and 'spacer' in Ldb1 LID .
To confirm that the tethered Lhx3 LIM1 þ 2 -Ldb1 LID construct mimicked the native complex, we used a construct that contained a Factor Xa protease site in the linker.
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N-HSQC spectra from this variant before and after protease treatment are essentially identical (Supplementary data 3B and C), demonstrating that the conformations of Lhx3 and Ldb1 LID are equivalent in the intra-and intermolecular complexes.
The crystal structure of Lhx3 LIM1 þ 2 -Isl1 LBD The structure of the Lhx3 LIM1 þ 2-Isl1 LBD complex was determined using native and multiple anomalous dispersion data (collected at the Zn X-ray absorption edge) recorded to 2.05 and 2.30 Å resolution, respectively. The R and R free values Values for the highest resolution shell are given in parentheses. a Native set data from Bhati et al (2008) .
Figure of merit after SOLVE phasing. presented in Table II are consistent for an X-ray crystal structure to 2.05 Å resolution with disordered regions arising from the missing loop between Lhx3 LIM1 þ 2 and the Isl1 LBD . There were two molecules of Lhx3-Isl1 LBD in the asymmetric unit, a monomer and a half-dimer, where the other half of the dimer comes from a symmetry-related molecule ( Figure 2D and E). The structured regions of the monomer comprise Lhx3 residues 28-153 (plus two N-terminal residues, GS, derived from the vector) and Isl1 residues 262-288, forming an extended rod-like complex that resembles the solution structure of Lhx3 LIM1 þ 2 -Ldb1 LID (Figure 2A and D). The dimer comprises Lhx3 residues 32-154 and Isl1 residues 262-286, and is effectively a domain-swapped version of the monomer. The N-terminal half of Isl1 LBD (residues 262-273) binds its own intramolecular partner at the LIM2 domain of Lhx3, but is bent around by nearly 1801 through Isl1 LBD residues 274-278 (the Isl1 LBD spacer) such that the remaining half of the Isl1 LBD segment (residues 279-286) contacts the LIM1 domain of Lhx3 in the symmetry-related molecule. Data from gel filtration monitored by multiangle (Koradi et al, 1996) .
laser light scatting revealed that the protein is monomeric in solution (Supplementary data 4), indicating that the 1:1 complex represents the dominant biological species (see Discussion for possible functional hints suggested by the domain-swapped dimer). When the LIM1 domains of the different oligomeric forms of the Lhx3-Isl1 LBD complex are overlaid, it can be seen that the orientation of the two LIM domains with respect to each other differs; the LIM2 domain of the dimer has swung 'downwards' from the hinge between the domains by B401 ( Figure 2F ). However, apart from differences that appear to be associated with the spacer residues in Isl1 LBD and the hinge region of Lhx3, the two halves of the different oligomeric forms are essentially identical: the backbone RMSDs for Lhx3 LIM1 (residues 32-89) are 0.86 Å and for Lhx3 LIM2 (residues 90-152) are 0.83 Å , and the contacts between Lhx3 and Isl1 are identical.
Geometry of the Lhx3 LIM1 þ 2 /peptide complexes The LIM domains from the different structures conform to the typical LIM domain topology (Perez-Alvarado et al, 1996; Supplementary data 5), and are very similar to each other. RMSDs over the backbone residues of Lhx3 from the lowest energy member of the NMR ensemble of Lhx3-Ldb1 LID and the Lhx3-Isl1 LBD monomer are 1.8 Å for Lhx3 LIM1 and 1.3 Å for Lhx3 LIM2 . However, the relative orientation of the two LIM domains differs in the different complexes (Supplementary data 5).
In the Lhx3-Ldb1 LID and Lhx3-Isl1 LBD structures, the Isl1/ Ldb1 peptides bind both LIM domains from Lhx3 in an extended manner, forming b-strand(s) that pack in an antiparallel fashion against the second b-hairpin in each of the first and fourth Zn-ligating modules (Zn1 and Zn4, respectively; Figure 2A and D). Isl1 LBD forms an additional b-strand that packs against the equivalent hairpin in the second Zn-ligating module in Lhx3 (Zn2), and interdomain backbone-backbone hydrogen bonds suggest that some b-strand is also forming in Ldb1 LID where it packs against the second b-hairpin in the third Zn-ligating module (Zn3; Figure 3A ). In the case of the Lhx3-Ldb1 complex, 3500-3600 Å 2 of surface area is buried at the interface between the two proteins, whereas the Lhx3-Isl1 complex buries B3250 Å 2 . Both interactions involve a combination of main-chain and side-chain hydrogen bonds, hydrophobic interactions and some electrostatic interactions ( Figure 3A and B) .
Despite low sequence homology, the backbone and many of the side-chain atoms of the Lhx3-binding peptides occupy identical positions on the surface of Lhx3 ( Figure 3C and D) . The main differences occur within the spacers of the binding domains. A structure-based alignment of those domains ( Figure 3E ) reveals two binding sites of nine and seven residues, separated by a variable length (six and nine residues in Isl1 LBD and Ldb1 LID , respectively) spacer. The increased flexibility noted above for residues in the Ldb1 LID spacer is also consistent with the poor alignment of these residues between Ldb1 LID and Isl1 LBD and indicates that this stretch does not have an important role in recognition.
Mutagenic analysis of the interface
We used alanine scanning mutagenesis to look for key binding determinants of peptide/LIM-HD interactions. Sets of three residues in Ldb1 LID and Isl1 LBD were systematically mutated to alanine (and subsequently single and double point mutants were made) and tested for binding to LIM domain constructs of Lhx3 using Y2H (Table III and Figure 3F and G).
Mutations in either the N-or C-terminal halves of Ldb1 LID were able to reduce binding to Lhx3 LIM1 þ 2 . Ldb1 LID -V303, which packs against the surface of Lhx3 LIM2 and is only partially buried, had the strongest effect when mutated to alanine. I322 and M302, which are highly buried in the interface between Ldb1 and Lhx3 LIM1 and Lhx3 LIM2 , respectively, had a more moderate effect when mutated. V304 and L309 were identified as having a weak effect on the interaction when mutated. These residues are buried in the Ldb1/ Lhx3 LIM2 interface. Only Lhx3 LIM2 and not Lhx3 LIM1 was able to independently bind Ldb1 LID , indicating that although both 'halves' of the interaction contribute to binding, the main binding determinants lie between the N-terminal half of Ldb1 and Lhx3 LIM2 .
Only mutations in the N-terminal half of Isl1 LBD reduced binding to Lhx3 LIM1 þ 2 , and only Lhx3 LIM2 was able to independently bind the Isl1 peptide, showing that the main binding determinants between Isl1 and Lhx3 also lie in the N-terminal half of the peptide-binding domain and Lhx3 LIM2 . The residues in Isl1 LBD that when mutated had the most effect on binding were M265 and A267, which are both highly buried at the interface. Notably, the key binding residues for the two complexes from our mutagenic data occupy very different physical spaces: Isl1 A267 is buried in a hydrophobic pocket formed between Zn1 and Zn2 in Lhx3 LIM1 , whereas Ldb1 V303 lies flat on the surface of Lhx3 LIM1 ( Figure 3F and G) .
The peptides were also tested for binding against the LIM domains of Isl1. There was no evidence of an intermolecular interaction between Isl1 LIM1 þ 2 and Isl1 LBD . However, in contrast to Lhx3, Isl1 LIM1 but not Isl1 LIM2 , could mediate an interaction with Ldb1 LID . Mutation of several residues in the C-terminal half of Ldb1 LID impaired binding to Isl1 LIM1 þ 2 and Isl1 LIM1 , but no mutation in the N-terminal half of Ldb1 LID perturbed binding to Isl1 LIM1 þ 2 . These data indicate that the most important contacts are made between Isl1 LIM1 and the C-terminal half of Ldb1 LID , which is consistent with published glutathione-S-transferase (GST) pulldown data for this interaction (Jurata et al, 1996) . However, mutations made against a background of the I322A mutation revealed that residues in the N-terminal half of Ldb1 (especially residues M302 and V303) are important in binding.
Relative stabilities of the LIM complexes
Having confirmed that both Lhx3 and Isl1 bind the same domain on Ldb1 and having determined that both Ldb1 and Isl1 bind the same site on Lhx3, we next sought to measure binding affinities for these different competing interactions to establish which complexes would be likely to form in vivo. Because the LIM domains of Isl1 and Lhx3 tend to be insoluble and prone to aggregation, it is not possible to measure the affinities using typical biophysical approaches. Thus, for the Ldb1/Lhx3 and Ldb1/Isl1 interactions, we generated tethered versions of the LIM-LID complexes where the linker contained a Factor Xa protease site ( Figure 4A, inset) . The tethered constructs were produced as GST fusion proteins and the linkers cut with Factor Xa to yield stable intermolecular LIM/LID and LIM/LBD com-plexes. FLAG-tagged Ldb1 LID was then used to compete off the unlabelled peptide in a competition ELISA, yielding dissociation constants of 35 nM for Lhx3/Ldb1 LID and 90 nM for Isl1/Ldb1 LID ( Figure 4A ).
The competition ELISA approach used above did not yield good quality data for Lhx3 LIM1 þ 2 -Isl1 LBD , so we instead compared the relative stability of Lhx3-Ldb1 LID and Lhx3-Isl1 LBD constructs to chemical denaturation monitored by tryptophan fluorescence ( Figure 4B ). The Lhx3 domains and the linkers in each case are identical, thus any differences in the stability of the different complexes should correlate with relative differences in binding of the LIDs. We used constructs of tethered complexes in both orientations (i.e., LID-LIM and LIM-LID) to control for any differences in stability conferred by the position of the linker (Jeffries et al, 2006) : these differences were very small for either pairing. Importantly, it was evident that the Isl1 LBD -containing complexes were significantly less resistant to GdnHCl denaturation than the Ldb1 LID -containing complexes (midpoint of denaturation B3.4 versus 5.8 M GdnHCl, respectively). Thus, although it was not possible to determine dissociation constants by this approach, Isl1 LBD appears to bind Lhx3 with significantly lower affinity than does Ldb1 LID .
Estimating the population distributions of Ldb1-, Lhx3-and Isl1-containing complexes
We then used our binding data and the program DynaFit3 (Kuzmic, 1996) to model the relative populations of the various binary and ternary complexes containing Ldb1, Lhx3 and Isl1, together with DNA sequences containing either single or double sites for either or both the HDs of Lhx3 and Isl1 ( Figure 4C -E and Supplementary data 7). As the effective local concentrations of these proteins within the nucleus are unknown, this modelling was designed to assess trends over a range of different conditions rather than to predict actual concentrations of complexes. Protein concen- T130 G131  D132  E133  F134   Y135   V301   Q110  F134  L136   M302  V304  E306  T308  G312  F314   T91  I100   G131  D132   V105  F85  F86   D316  D318  R320  I322   K82   L47  A49  L59  A69  E70  C72  V106   R107  L128  A129  T130  D132  F134   Y135   N327 L325   E326   I100  Q104  V106  V113   P102  P102   F73  F85   K48  I46   K82   R44   I46   A69 M310 D300
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trations in the range 1 nM up to 1 mM were used, taking into account both the predicted concentrations of nuclear transcription factors (B1-100 nM) (Ryan et al, 2007) and the possibility of local concentration effects, which might give rise to much higher effective concentrations. Equal concentrations of all starting components were used.
If we just consider the competition of Lhx3 and Isl1 for Ldb1 (i.e., ignoring both Isl1 LBD and DNA; Figure 4C ), simulations carried out at different concentrations reveal that in the absence of any other interactions, Ldb1 LID exhibits a preference for binding Lhx3 over Isl1 at the level of approximately two-fold more Lhx3/Ldb1 rather than Isl1/Ldb1 
Summary of deletion and alanine scanning mutagenesis screens of Ldb1 LID and Isl1 LBD against Isl1 and Lhx3 using the yeast two-hybrid assay. The stringency of selection conditions was moderate (-L-W-H 1 mM 3-AT)/high (-L-W-H-A), except for the bold boxed interactions for Lhx3 LIM2 in which they were low (-L-W-H 0.5 mM 3-AT)/moderate (-L-W-H 1 mM 3-AT). +++ indicates growth in 10 0 , 10 À1 and 10 À2 dilutions, ++ indicates growth only in 10 0 and 10 À1 , + indicates growth only in 10 0 , B indicates minor levels of growth only in 10 0 and À indicates no growth at any dilution used. Combinations marked ND were not determined. Ldb1 LID and Isl1 LBD constructs were in pGBT9 and Lhx3 was in pGAD10, except for the results in the bounded ( ¼ ) box in which the vector/construct combinations were reversed. complexes being formed (e.g., 2.5-fold at 1 nM protein concentrations and 1.9-fold at 100 nM protein concentrations).
If we additionally consider the Lhx3-Isl1 interaction in our model ( Figure 4D ), we find that the ternary Lhx3/Isl1/Ldb1 complex is unlikely to be significantly populated. Even in the presence of DNA ( Figure 4E ), ternary complex formation (right-hand bars in Figure 4E ) is favoured only if the four HDs in the ternary complex can bind simultaneously to multiple DNA sites (SA series) and gain a free energy 'bonus' through the chelate effect (the reduction of entropy loss when binding a second site on the same molecule; Figure 4E ).
The other situation in which the ternary complex is favoured, even in the absence of DNA, arises when the protein concentrations are set to be very high (mM concentrations; Supplementary data 7). Finally, the modelling data also indicate that significant levels of Lhx3-Ldb1 and Isl1-Ldb1 complexes are also likely to be present in cells in which Lhx3, Isl1 and Ldb1 are all coexpressed.
Discussion
The formation of cell-specific LIM-HD-containing complexes The data from this study reveal that Isl1 is able to alter the nature of transcriptional complexes formed by Lhx3 and Ldb1 at neuronal promoters by binding Lhx3 through a decoy peptide domain within its own C terminus and allowing Isl1 to instead bind Ldb1 LID . The subsequent formation of the ternary Ldb1/Isl1/Lhx3 complex appears to be driven by enhanced binding to DNA sequences that contain multiple HD-binding sites. In support of this model, only constructs that can form ternary complexes (or artificial analogues of ternary complexes) with intact HDs from both Lhx3 and Isl1 can trigger motor neuron differentiation in cell lines (Thaler et al, 2002) . Moreover, the enhancer for a key target of the ternary Ldb1/Isl1/Lhx3 complex in motor neuron development, Hb9 (Thaler et al, 1999) , is bound only when both Lhx3 and Isl1 are present; neither Lhx3 nor Isl1 alone can bind (Lee and Pfaff, 2003) . Thus, the ternary complex appears to be able to target different sets of genes compared with binary Ldb1/Lhx3 or Ldb1/Isl1 complexes. It is also possible that Ldb1/Lhx3 and Ldb1/Isl1 complexes are recruited to the vicinity of the motor neuron sites by interactions between Ldb1 and other transcription factors (Lee and Pfaff, 2003) .
The common occurrence of Isl1/Lhx3 complexes Isl1 LBD is a common feature in Isl proteins from complex organisms (Supplementary data 8) . Residues in the spacer region can vary considerably, whereas residues within the binding motifs tend to be highly conserved. Lhx3 family proteins are also found in the same organisms, suggesting that the Isl/Lhx3 interaction is highly conserved and has been central to nervous system development from its evolutionary beginnings. It should be noted that the interaction of Lhx3 and Isl1 is not restricted to V2 interneurons and/or motor neurons; the two proteins interact in pituitary cells to regulate expression of the gonadotropin-releasing hormone receptor (Granger et al, 2006) . Notably, the promoter of the folliclestimulating hormone b gene contains at least six HD-binding elements that might be recognised by ternary complexes (West et al, 2004) .
A comparison of LIM-Ldb1 LID complexes
We have previously determined structures of LIM domains from LMO proteins in complex with Ldb1 LID (Deane et al, 2003 (Deane et al, , 2004 Jeffries et al, 2006) . The relative orientations of the LIM domains from tandem LIM structures of LMO4 and Lhx3 differ, but the LIM1 and LIM2 domains are very similar, despite small gaps within the sequence alignments of these LIM domains ( Figure 5A and Supplementary data 6). Although equivalent residues in the LIM domains contact Ldb1 LID , the sequence conservation of those residues varies ( Figure 5A ). However, apart from significant structural differences around the hinge/spacer regions, there is a high level of structural conservation at the LIM/LID interfaces ( Figure 5B and C) . Mutagenic screens of Ldb1 LID versus four different LMO and LIM-HD proteins (Deane et al, 2004; Ryan et al, 2006;  this study) implicate similar residues in Ldb1 LID as important for binding ( Figure 5D ). Several guiding principles emerge for Ldb1 LID/ LIM interactions: (i) Ldb1 I322 is the key residue for binding LIM1; (ii) Ldb1 V303 is the key residue for binding LIM2 with a secondary cluster of residues around Ldb1 L309 ; (iii) mutations in both halves are often required to abrogate binding; and (iv) there is little or no contribution of residues from the spacer region in Ldb1 LID to binding, indicating that Ldb1 LID binds the tandem LIM domains of both LIM-HD and LMO proteins through two closely spaced binding motifs ( Figure 5D ). Thus, apart from different relative orientations of the two halves of the complexes, it is likely that Ldb1 LID binds all LMO/LIM-HD proteins in fundamentally the same manner. C A mechanism for exchanging partners The modular nature of LIM-peptide interactions, the apparent flexibility of the Ldb1 LID spacer and the observation that the Isl1 LBD can adopt different conformations ( Figure 2E ) all suggest a molecular mechanism for the disruption of the preferred Lhx3/Ldb1 complex by Isl1 (Figure 6 ). Lhx3 bound to Ldb1 LID ( Figure 6A ) makes stronger contacts through Lhx3 LIM2 . It is possible that Lhx3 LIM1 periodically becomes 'unstuck' whereas Lhx3 LIM2 remains in contact with Ldb1 LID ( Figure 6B ). When Isl1 is introduced to this half-complex, it is free to bind to Ldb1 LID through its favoured half (Isl1 LIM1 ), leaving Lhx3 LIM2 bound to the N-terminal half of Ldb1 LID ( Figure 6C ). Isl1 LBD would now be in close proximity to the Lhx3 LIM domains, encouraging the formation of an Isl1 LBD / Lhx3 LIM1 interaction ( Figure 6D ). Although this interaction is likely to be weak, it would be enhanced by the chelate effect. A final rearrangement of the LIM-LID interactions ( Figure 6E and F) would give rise to the Ldb1/Isl1/Lhx3 complex.
Tandem binding motifs as mediators of protein signalling networks
Many protein:protein interactions are regulated through intrinsically unstructured motifs that take up a defined structure on binding to their partner (Dyson and Wright, 2005) . More than 30% of protein sequence within eukaryotes is predicted to be intrinsically unstructured (Ward et al, 2004) , and these regions exhibit a preponderance of short repeated sequences that vary in length and number of repeats (Tompa, 2003) . The Lhx3-binding domains characterised here resemble tandemly arrayed linear motifs, although they lack the sequence conservation through which linear motifs have thus far been identified (Neduva and Russell, 2006) . Given our observations of tandem binding repeats with very low levels of sequence homology, we suggest that tandem binding events between unstructured domains and folded protein domains could be extremely common. Despite the plethora of newly defined unstructured domains in the literature, the majority of unstructured domains are yet to be characterised. For example, LIM-HD proteins (and indeed the majority of transcription factors) all contain long stretches of putatively unstructured protein sequence. We predict that other interactions mediated by intrinsically unstructured domains within LIM-HDs will have significant roles in establishing the identity of developing cells through the implementation of transcriptional LIM codes. Thus, it is likely that tandemly arrayed interaction motifs competing for binding to target proteins will emerge as an important general strategy for the formation and dynamics of multiprotein complexes.
Materials and methods
Cloning, mutagenesis and protein expression All clones and mutants were generated by PCR and sequenced to confirm identity (SUPAMAC, Royal Prince Alfred Hospital, Sydney). 
